Publikationen, an denen er mitarbeitet RUBÉN MARTÍN ESCOLANO (17)

2023

  1. Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †

    Pharmaceutics, Vol. 15, Núm. 1

2022

  1. 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii

    Acta Tropica, Vol. 232

  2. An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

    ACS infectious diseases, Vol. 8, Núm. 6, pp. 1107-1115

  3. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery

    Acta Tropica, Vol. 236

2021

  1. In vitro anti-Acanthamoeba activity of flavonoid glycosides isolated from Delphinium gracile, D. staphisagria, Consolida oliveriana and Aconitum napellus

    Parasitology, Vol. 148, Núm. 11, pp. 1392-1400

  2. Library of selenocyanate and diselenide derivatives as in vivo antichagasic compounds targeting trypanosoma cruzi mitochondrion

    Pharmaceuticals, Vol. 14, Núm. 5

  3. Selenium Derivatives as Promising Therapy for Chagas Disease: In Vitro and in Vivo Studies

    ACS Infectious Diseases, Vol. 7, Núm. 6, pp. 1727-1738

2020

  1. Assessing the effectiveness of AS-48 in experimental mice models of Chagas' disease

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 6, pp. 1537-1545

  2. In Vivo Biological Evaluation of a Synthetic Royleanone Derivative as a Promising Fast-Acting Trypanocidal Agent by Inducing Mitochondrial-Dependent Necrosis

    Journal of Natural Products, Vol. 83, Núm. 12, pp. 3571-3583

  3. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition

    Parasitology Research, Vol. 119, Núm. 9, pp. 2943-2954

2019

  1. Effective tetradentate compound complexes against leishmania spp. that act on critical enzymatic pathways of these parasites

    Molecules, Vol. 24, Núm. 1

  2. Insights into Chagas treatment based on the potential of bacteriocin AS-48

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 10, pp. 1-8

  3. New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases

    European Journal of Medicinal Chemistry, Vol. 164, pp. 27-46

  4. Preclinical studies of toxicity and safety of the AS-48 bacteriocin

    Journal of Advanced Research, Vol. 20, pp. 129-139

2017

  1. Tetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine model

    Journal of Chemotherapy, Vol. 29, Núm. 2, pp. 83-93

2016

  1. Effective anti-leishmanial activity of minimalist squaramide-based compounds

    Experimental Parasitology, Vol. 170, pp. 36-49

2015

  1. An invitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase

    International Journal for Parasitology: Drugs and Drug Resistance, Vol. 5, Núm. 3, pp. 110-116